Oppenheimer Reiterates Outperform Rating on Tectonic Therapeutics Inc. (TECX)

September 30, 2026 5:59 AM EDT Send to a Friend
Oppenheimer analyst Leland Gershell reiterated an Outperform rating and $80.00 price target on Tectonic Therapeutics Inc. (NASDAQ: TECX).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login